← Insider buys

Omega Fund V, L.P. has bought stock on 2 days since May 2019

10% owner at Nuvation Bio Inc., and 3 other companies

SEC CIK 0001641354 · Filings on SEC.gov ↗

$6.8MBought
$102.6MSold
Jul 1Last buy

Omega Fund V, L.P.'s record

3 months after each buy, from the first price a copier could get.

No buys have 3 months of prices yet. A record shows here at 3.

Companies

Every filing

50 filings since May 2019, newest first

NUVBSell

Nuvation Bio Inc.

10% owner

$14.0M−11.0%Apr 7
NUVBSell

Nuvation Bio Inc.

10% owner

$5.0M−2.0%Dec 17
NUVBSell

Nuvation Bio Inc.

10% owner

$2.9M−1.0%Nov 24
NUVBSell

Nuvation Bio Inc.

10% owner

$18.5M−7.0%Nov 5
NUVBSell

Nuvation Bio Inc.

10% owner

$10.2M−4.0%Nov 1
MORFSell

Morphic Holding, Inc.

Director

$938K−1.0%May 3
MORFSell

Morphic Holding, Inc.

Director

$593K−1.0%Apr 29
MORFSell

Morphic Holding, Inc.

Director

$774K−1.0%Apr 27
MORFSell

Morphic Holding, Inc.

Director

$1.1M−1.0%Apr 23
MORFSell

Morphic Holding, Inc.

Director

$971K−1.0%Apr 21
MORFSell

Morphic Holding, Inc.

Director

$987K−1.0%Apr 19
MORFSell

Morphic Holding, Inc.

Director

$1.2M−1.0%Apr 15
MORFSell

Morphic Holding, Inc.

Director

$1.4M−1.0%Apr 13
MORFSell

Morphic Holding, Inc.

Director

$1.6M−1.0%Apr 9
MORFSell

Morphic Holding, Inc.

Director

$1.3M−1.0%Apr 7
MORFSell

Morphic Holding, Inc.

Director

$1.9M−1.0%Apr 2
MORFSell

Morphic Holding, Inc.

Director

$2.2M−2.0%Mar 31
MORFSell

Morphic Holding, Inc.

Director

$2.8M−2.0%Mar 29
MORFSell

Morphic Holding, Inc.

Director

$3.2M−2.0%Mar 25
MORFSell

Morphic Holding, Inc.

Director

$1.6M−1.0%Mar 23
MORFSell

Morphic Holding, Inc.

Director

$2.3M−1.0%Mar 19
MORFSell

Morphic Holding, Inc.

Director

$4.2M−3.0%Mar 17
MORFSell

Morphic Holding, Inc.

Director

$1.3M−1.0%Mar 1
MORFSell

Morphic Holding, Inc.

Director

$360KFeb 25
MORFSell

Morphic Holding, Inc.

Director

$382KFeb 23
MORFSell

Morphic Holding, Inc.

Director

$572K−1.0%Feb 19
MORFSell

Morphic Holding, Inc.

Director

$310KFeb 17
MORFSell

Morphic Holding, Inc.

Director

$379KFeb 12
MORFSell

Morphic Holding, Inc.

Director

$876K−1.0%Feb 10
MORFSell

Morphic Holding, Inc.

Director

$587K−1.0%Feb 8
MORFSell

Morphic Holding, Inc.

Director

$2.0M−2.0%Feb 4
MORFSell

Morphic Holding, Inc.

Director

$693K−1.0%Feb 2
MORFSell

Morphic Holding, Inc.

Director

$680K−1.0%Jan 29
MORFSell

Morphic Holding, Inc.

Director

$507K−1.0%Jan 27
MORFSell

Morphic Holding, Inc.

Director

$308KJan 25
MORFSell

Morphic Holding, Inc.

Director

$518K−1.0%Jan 21
MORFSell

Morphic Holding, Inc.

Director

$718K−1.0%Jan 19
MORFSell

Morphic Holding, Inc.

Director

$376KJan 15
MORFSell

Morphic Holding, Inc.

Director

$374KJan 12
MORFSell

Morphic Holding, Inc.

Director

$846K−1.0%Jan 8
MORFSell

Morphic Holding, Inc.

Director

$810K−1.0%Jan 6
MORFSell

Morphic Holding, Inc.

Director

$525K−1.0%Jan 4
MORFSell

Morphic Holding, Inc.

Director

$637K−1.0%Dec 30
MORFSell

Morphic Holding, Inc.

Director

$399KDec 28
GOSSSell

Gossamer Bio, Inc.

10% owner

$4.0M−3.0%Sep 23
GOSSSell

Gossamer Bio, Inc.

10% owner

$1.8M−1.0%Sep 18
GOSSSell

Gossamer Bio, Inc.

10% owner

$2.4M−2.0%Sep 12
GOSSSell

Gossamer Bio, Inc.

10% owner

$462KSep 9
MORFBuy

Morphic Holding, Inc.

10% owner

$2.0M+5.0%Jul 1
TRVIBuy

Trevi Therapeutics, Inc.

10% owner

$4.8M+83.0%May 13

Filings come from SEC EDGAR. Not investment advice.